glp 1 agonist crohn's disease Ozempic and Disease: Could GLP-1s Help? GLP-1 Use in Crohn's Disease:

Efficacy and safety of once-weekly semaglutide versus once-daily sitagliptin as an add-on to metformin, thiazolidinediones, or both, in patients with type 2 diabetes (SUSTAIN 2): A 56-week, double-blind, phase 3a, randomised trial

Human No studies regarding the use of SGLT2 inhibitors during lactation in humans were found

10.1186/s12933-021-01366-8

Male B6.V-Lepob/JRj (ob/ob) mice were purchased from Cavens Experimental Center (Changzhou, China)

In contrast, both semaglutide and tirzepatide treated groups showed a significant reduction in liver fibrosis compared to their respective diet-restricted controls

Obesity is also a major driver of non-communicable diseases such as cardiovascular disease and some cancers